Foundations Investment Advisors’s IceCure Medical ICCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-500
Closed -$4.51K 1258
2026
Q1
$4.51K Hold
500
﹤0.01% 1160
2025
Q4
$9.15K Hold
500
﹤0.01% 1104
2025
Q3
$15.2K Hold
500
﹤0.01% 1037
2025
Q2
$14.9K Hold
500
﹤0.01% 913
2025
Q1
$17.6K Buy
+500
New +$19.6K ﹤0.01% 850
2024
Q4
Sell
-333
Closed -$6.1K 861
2024
Q3
$6.1K Hold
333
﹤0.01% 816
2024
Q2
$7.4K Hold
333
﹤0.01% 750
2024
Q1
$12K Hold
333
﹤0.01% 698
2023
Q4
$14.2K Buy
+333
New +$8.82K ﹤0.01% 660

Other funds holding ICCM

Foundations Investment Advisors's ICCM Position: Q2 2026 in Review

Foundations Investment Advisors sold out of IceCure Medical (ICCM) in Q2 2026, closing a stake of 500 shares — an estimated $4.51K sold.

Foundations Investment Advisors first reported a position in ICCM in Q4 2023 and held it in 9 quarters. The position peaked at $17.6K in Q1 2025. 11 funds tracked by Wall St. Rank hold ICCM as of Q2 2026.

  • Foundations Investment Advisors reported no remaining IceCure Medical position as of Q2 2026 after selling out during the quarter.
  • Foundations Investment Advisors sold 500 IceCure Medical shares in Q2 2026, an estimated $4.51K.
  • Foundations Investment Advisors first reported a position in IceCure Medical in Q4 2023 and held it in 9 quarters.
  • Foundations Investment Advisors's IceCure Medical position peaked at $17.6K in Q1 2025.
  • 11 funds tracked by Wall St. Rank held IceCure Medical as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.